Inventor
William John Farnaby
Inventor
Cambridge, GB
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
11,129,828Pyridazinone compounds and their use as DAAO inhibitors202110,717,7481-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases202010,550,1291-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases202010,463,663Pyridazinone compounds and their use as DAAO inhibitors201910,273,2451-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases201910,144,7431-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases201810,100,018Amide derivatives as lysophosphatidic acid receptor antagonists201810,085,986Pyrimidinone compounds and their use201810,059,7133-substituted 2-amino-indole derivatives20189,931,340Pyridazinone compounds and their use as DAAO inhibitors20189,750,748'Pyridazinones as DAAO enzyme inhibitors'20179,598,398'Heterocyclic compound'20179,586,930'1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases'20179,464,060'Compounds'20169,440,990'1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases'20169,290,456'Pyridazinone compounds and their use as DAAO inhibitors'20169,193,709'1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases'20159,180,122'5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain'20158,871,766'Heterocyclic compounds'20148,865,717'Heterocyclic compounds'20148,648,079'Heterocyclic compounds'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2016Patents assigned to TAKEDA PHARMACEUTICAL (6)· patent assignee history
2014–2021Based in Cambridge, GB· patent location history
2015–2018Patents assigned to FARNABY WILLIAM (3)· patent assignee history
2015–2018Patents assigned to KINSELLA NATASHA (3)· patent assignee history
2015–2018Patents assigned to MERCHANT KEVIN (3)· patent assignee history
2016–2021Patents assigned to TAKEDA PHARMACEUTICALS CO (15)· patent assignee history
2018Based in Cambridgeshire, GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 15 | 2016–2021 |
| TAKEDA PHARMACEUTICAL | 6 | 2014–2016 |
| FARNABY WILLIAMself | 3 | 2015–2018 |
| KINSELLA NATASHA | 3 | 2015–2018 |
| MERCHANT KEVIN | 3 | 2015–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cambridge, GB | 20 | 2014–2021 |
| Cambridgeshire, GB | 1 | 2018 |